SCHEMBL30973045

SCHEMBL30973045

Cc1cc(Cl)cc(O)c1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
TSHR P16473 4/20 0.41
HPGD P15428 2/20 0.41
CYP3A4 P08684 4/20 0.37
ALOX15 P16050 2/20 0.37
CHRM1 P11229 1/20 0.37
MAOA P21397 1/20 0.37
TBXA2R P21731 1/20 0.37
ADRA1A P35348 1/20 0.37
HTR2B P41595 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
RECQL P46063 1/20 0.35
ESR2 Q92731 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 3/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GAA P10253 1/20 0.33
ACLY P53396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25085872 1.00 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL1445955 0.82 TSHR (0.41) ALDH1A1HSD17B10TSHRCYP3A4ALOX15
SCHEMBL2172009 0.77 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL1505303 0.77 RAPGEF4 (0.45) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL2933421 0.75 ALDH1A1 (0.44) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL31090197 0.75 SELL (0.50) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL2654350 0.75 SELL (0.50) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL565244 0.75 TSHR (0.56) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL7724604 0.75 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL29768378 0.75 TSHR (0.56) ALDH1A1HSD17B10TSHRHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638438-A1 ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF Xinthera, Inc. (US) 2025-10-29 EP disclosed
WO-2024138042-A1 ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF XINTHERA, INC. (US) 2024-06-27 WO disclosed